Form 8-K - Current report:
SEC Accession No. 0001708599-25-000044
Filing Date
2025-04-15
Accepted
2025-04-15 06:33:57
Documents
51
Period of Report
2025-04-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ser-20250415.htm   iXBRL 8-K 25957
2 EX-99 ex992_041520254thlnpsummit.htm EX-99 9174
3 EX-99.1 ex991-4thlnpformulationp.htm EX-99.1 32188
7 ex991-4thlnpformulationp001.jpg GRAPHIC 65252
8 ex991-4thlnpformulationp002.jpg GRAPHIC 83399
9 ex991-4thlnpformulationp003.jpg GRAPHIC 248155
10 ex991-4thlnpformulationp004.jpg GRAPHIC 76818
11 ex991-4thlnpformulationp005.jpg GRAPHIC 152932
12 ex991-4thlnpformulationp006.jpg GRAPHIC 70308
13 ex991-4thlnpformulationp007.jpg GRAPHIC 141146
14 ex991-4thlnpformulationp008.jpg GRAPHIC 105264
15 ex991-4thlnpformulationp009.jpg GRAPHIC 130702
16 ex991-4thlnpformulationp010.jpg GRAPHIC 148352
17 ex991-4thlnpformulationp011.jpg GRAPHIC 141813
18 ex991-4thlnpformulationp012.jpg GRAPHIC 133148
19 ex991-4thlnpformulationp013.jpg GRAPHIC 123668
20 ex991-4thlnpformulationp014.jpg GRAPHIC 148682
21 ex991-4thlnpformulationp015.jpg GRAPHIC 117326
22 ex991-4thlnpformulationp016.jpg GRAPHIC 147223
23 ex991-4thlnpformulationp017.jpg GRAPHIC 92419
24 ex991-4thlnpformulationp018.jpg GRAPHIC 133757
25 ex991-4thlnpformulationp019.jpg GRAPHIC 153556
26 ex991-4thlnpformulationp020.jpg GRAPHIC 154245
27 ex991-4thlnpformulationp021.jpg GRAPHIC 161522
28 ex991-4thlnpformulationp022.jpg GRAPHIC 108250
29 ex991-4thlnpformulationp023.jpg GRAPHIC 98504
30 ex991-4thlnpformulationp024.jpg GRAPHIC 86933
31 ex991-4thlnpformulationp025.jpg GRAPHIC 163514
32 ex991-4thlnpformulationp026.jpg GRAPHIC 116297
33 ex991-4thlnpformulationp027.jpg GRAPHIC 88797
34 ex991-4thlnpformulationp028.jpg GRAPHIC 82574
35 ex991-4thlnpformulationp029.jpg GRAPHIC 106907
36 ex991-4thlnpformulationp030.jpg GRAPHIC 121271
37 ex991-4thlnpformulationp031.jpg GRAPHIC 97865
38 ex991-4thlnpformulationp032.jpg GRAPHIC 85783
39 ex991-4thlnpformulationp033.jpg GRAPHIC 85760
40 ex991-4thlnpformulationp034.jpg GRAPHIC 112611
41 ex991-4thlnpformulationp035.jpg GRAPHIC 158328
42 ex991-4thlnpformulationp036.jpg GRAPHIC 70289
  Complete submission text file 0001708599-25-000044.txt   6236598

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ser-20250415.xsd EX-101.SCH 1800
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ser-20250415_lab.xml EX-101.LAB 54435
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ser-20250415_pre.xml EX-101.PRE 31811
53 EXTRACTED XBRL INSTANCE DOCUMENT ser-20250415_htm.xml XML 2820
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 25837507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)